UK Variant
- India
Increase in gap between Covishield doses based on scientific evidence: NTAGI
New Delhi: The decision to increase the gap between two Covishield doses from 4-6 weeks to 12-16 weeks is based on scientific reason regarding behaviour of adenovector vaccines, said Chairman of India’s Covid-19…
- Health
Pfizer, AstraZeneca jabs effective against ‘India variant’: Study
London: Two doses of either Pfizer and AstraZeneca coronavirus vaccine are highly effective against the B16172 variant, first identified in India, a new study has found. The vaccines were also found to give…
